Sibutramine (trade name Meridia in the USA, Leptos in India, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity, as an appetite suppressant. It is a centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines, although its mechanism of action is distinct.
3 edits since May 19, 2008. Last edited Jul 27, 2008 by SHAHINOVE (1).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Sibutramine. See this site's terms for details.